logo-loader
RNS
Acuity RM Group

Clarification of Warrant Terms

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

23 September 2026

Acuity RM Group Plc

("Acuity", or "the Company")

Clarification of Warrant Terms

 

Acuity RM Group plc (AIM: ACRM), the software group specialising in the cybersecurity sector of the Governance, Risk and Compliance ("GRC") market, takes the opportunity to provide the following clarification in relation to the terms of warrants issued in connection with the Company's equity fundraisings undertaken during May, July and September 2025.

As disclosed in the Company's Annual Report and Accounts for the year ended 31 December 2025, a total of 87,607,143 warrants were issued in connection with those fundraisings, each entitling the holder to subscribe for one new ordinary share of 0.1 pence in the Company at an exercise price of 1.50 pence per share (collectively "the 2025 Warrants").

Certain announcements made by the Company in connection with the fundraisings stated that the relevant warrants were exercisable for a period of 12 months. The Company wishes to clarify that, under the terms of the warrant instruments, the 2025 Warrants are actually exercisable for a period of 18 months from the admission of the shares subscribed for in those fundraisings.

The 2025 Warrants have a clause, whereby if the closing mid-market price of the Company's ordinary shares is 2.00 pence or greater for five consecutive trading days within 12 months, the Company can elect to invoke an accelerator provision and give notice to holders of the 2025 Warrants requiring them to exercise their warrants or allow them to lapse.

The table below sets out details of the share warrants issued, and for completeness includes the warrants recently issued in connection with the July 2026 fundraising ("the 2026 Warrants"). The 2026 Warrants do not have an accelerator provision and have an exercise period of 12 months.

Holders of the 2025 Warrants who have any questions or wish to exercise their warrants should contact the Company. Holders of the 2026 Warrants who have any questions or wish to exercise their warrants should contact Neville Registrars (0121 585 1131 / info@nevilleregistrars.co.uk).

The warrants are not generally transferrable.

Admission of subscribed shares

 

Expiry of accelerator provision

Expiry of warrants

Exercise price of warrants

Number of warrants

23 May 2025

23 May 2026

23 November 2026

1.50p

42,107,143

4 July 2025

4 July 2026

4 January 2027

1.50p

10,500,000

26 September 2025

26 September 2026

26 March 2027

1.50p

35,000,000

Total 2025 warrants

 

87,607,143

9 July 2026

Not applicable

8 July 2027

0.75p

61,052,728

Total warrants

148,659,871

The terms of the warrant instruments themselves have not been amended and the rights of all warrant holders remain as originally constituted. The correct terms were disclosed in the Company's Annual Report and Accounts for the year ended 31 December 2025.

For further information please contact:  

 

Acuity RM Group Plc 

Duncan Harper, Finance Director 

 

020 3582 0566

www.acuityrmgroup.com

 

Zeus Capital (NOMAD & Joint Broker) 

Mike Coe / James Bavister 

 

020 3829 5000 

www.zeuscapital.co.uk 

 

AlbR Capital (Joint Broker) 

Lucy Williams / Duncan Vasey 

 

020 7469 0936 

www.albrcapital.com 

Clear Capital Markets Limited (Joint Broker) 

Bob Roberts 

 

020 3869 6080 

www.clearcapitalmarkets.co.uk 

 

Note to Editors

 

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform which collects and analyses data to improve business decisions and management used by clients operating in markets including government, defence, broadcasting, utilities, manufacturing and healthcare.

 

The Group is focused on delivering long term, sustainable growth in shareholder value from organic growth and complementary acquisitions.

 

 




NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Exercise of Share Warrants

2 days, 15 hours ago

Further Contract Award

3 days, 15 hours ago

Holding in Company

1 week, 2 days ago

Exercise of Share Warrants

1 week, 3 days ago

Exercise of Share Warrants

2 weeks, 2 days ago

Exercise of Share Warrants

3 weeks, 1 day ago

Services Contract Award

4 weeks, 1 day ago

25 min read